Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Luigi Naldini, Samuele Ferrari et al.|Nature Biotechnology|2023Cited by 214
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cellsAttya Omer, Luigi Naldini, Gabriele Pedrazzani et al.|Cell|2022Cited by 56
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCsMohsen Hosseini, Steven M. Chan, Martina Fiumara et al.|Nature|2025Cited by 43
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Samuele Ferrari, Martina Fiumara et al.|Nature Medicine|2025Cited by 38
Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of <scp> CD4 <sup>+</sup> </scp> T‐cells for the treatment of Hyper <scp>IgM1</scp>Daniele Canarutto, Luigi Naldini, Claudia Asperti et al.|The EMBO Journal|2023Cited by 10